Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab

Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab

Multiple sclerosis subjects treated with natalizumab face anxiety about developing progressive multifocal leukoencephalopathy (PML), besides the psychological distress caused by the disease. The aim of this study is to investigate whether increasing the frequency of neurological and nuclear magnetic...

Full description

Bibliographic Details
Main Authors: Francesco Corallo, Edoardo Sessa, Carmela Rifici, Maria Cristina De Cola, Marcella Di Cara, Davide Cardile, Giuseppe Venuti, Noemi Bonfiglio, Giangaetano D’Aleo, Angelo Quartarone, Viviana Lo Buono
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Journal of Clinical Medicine
Subjects:
anxiety
disease control
multiple sclerosis
natalizumab
progressive multifocal leukoencephalopathy
Online Access:https://www.mdpi.com/2077-0383/13/1/13

Internet

https://www.mdpi.com/2077-0383/13/1/13

Similar Items